52). Additionally, methylation of BC-related genes could provide essential insights into treatment response prediction, allowing clinicians to personalise treatment options according to the needs of individual patients, as shown by research investigating APC, BRCA1, PTEN, TMEM240, ENPP2 and ESR1 methylation profiles (Supplementary Table S1). This evidence concerns the gene TMEM240 and breast cancer.